Cell intrinsic role of COX-2 in pancreatic cancer development

Reginald Hill1, Yunfeng Li, Linh M Tran

  • 1Corresponding Author: Hong Wu, Department of Molecular and Medical Pharmacology, CHS 33-131, 650 CE Young Drive South, Los Angeles, CA 90095, USA.

Insights

Cyclooxygenase-2 (COX-2) plays a cell-intrinsic role in pancreatic ductal adenocarcinoma (PDAC) development by activating the PI3K/AKT pathway. Inhibiting COX-2 may delay PDAC, but overcoming AKT-mediated chemoresistance is also crucial.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) shows upregulated Cyclooxygenase-2 (COX-2), but its specific role in tumor initiation and progression remains unclear.
  • Previous research focused on COX-2 inhibition using NSAIDs or celecoxib, without distinguishing between cell-intrinsic and microenvironment effects.
  • The interplay between COX-2, PTEN loss, and the PI3K/AKT pathway in PDAC pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the cell-intrinsic role of COX-2 in pancreatic cancer initiation and progression.
  • To elucidate the molecular mechanisms by which COX-2 influences PDAC development, particularly concerning the PI3K/AKT pathway.
  • To assess the potential of targeting COX-2 in PDAC treatment strategies.

Main Methods:

  • Utilized loss-of-function (Cox-2 deletion) and gain-of-function (COX-2 overexpression) approaches in genetically engineered mouse models (GEMMs) of PDAC.
  • Employed Pdx1-Cre, K-ras, and Pten conditional knockout mouse models to study PDAC development.
  • Analyzed molecular changes including p-AKT, FKBP5, and GRP78 expression levels in precursor lesions and tumors.

Main Results:

  • Cox-2 deletion in pancreatic progenitor cells significantly delayed PDAC development in mice with K-ras activation and Pten haploinsufficiency.
  • COX-2 overexpression accelerated PDAC onset and progression in the K-ras mouse model.
  • Mechanistically, COX-2 overexpression increased p-AKT levels, while Cox-2 deletion diminished them, indicating a role in PI3K/AKT pathway activation.
  • Alternative pathways involving FKBP5 and GRP78 can lead to AKT activation, driving PDAC progression independent of intrinsic COX-2.

Conclusions:

  • COX-2 exerts a significant cell-intrinsic role in PDAC initiation and progression, primarily through the activation of the PI3K/AKT pathway.
  • Targeting COX-2 may offer a therapeutic strategy to delay PDAC development and progression.
  • Overcoming compensatory AKT activation pathways is essential for enhancing the efficacy of anti-COX-2 therapies in PDAC treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...